Tue 05/16/2023 13:30 PM
Investors considering global specialty chemicals company Nouryon’s
term loan B amend-and-extend transaction highlighted that performance in the first quarter of the year was flat, and there is some uncertainty over the rest of this year. However, the group has a strong track record, has delevered significantly since its original buyout and benefits from scale as well as strong geographic and product diversification, they noted.
During the first quarter, adjusted EBITDA declined to $283...
This article is an example of the content you may receive if you subscribe to a product of Reorg Research, Inc. or one of its affiliates (collectively, “Reorg”). The information contained herein should not be construed as legal, investment, accounting or other professional services advice on any subject. Reorg, its affiliates, officers, directors, partners and employees expressly disclaim all liability in respect to actions taken or not taken based on any or all the contents of this publication. Copyright © 2024 Reorg Research, Inc. All rights reserved.